about
TMC207 for treatment of people with pulmonary tuberculosisFluoroquinolones for treating tuberculosis (presumed drug-sensitive)New Antituberculosis Drugs: From Clinical Trial to Programmatic UseEffects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-AnalysisA medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosisResearch questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analysesIntensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activationEmpirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia.Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised PatientsManaging TB in the 21st century: existing and novel drug therapies.Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.[Proposal of anti-tuberculosis regimens based on susceptibility to isoniazid and rifampicin].Management of multidrug-resistant tuberculosis: an update.Moxifloxacin as an alternative or additive therapy for treatment of pulmonary tuberculosis.Emerging drugs and alternative possibilities in the treatment of tuberculosis.Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients.Evaluation of the physicians' approach to the diagnosis and treatment of patients with antituberculosis drug-induced hepatotoxicity.
P2860
Q24199155-7C98D31B-8D4B-4AA4-8BBF-E1C87BEB0693Q24202081-B0FE658E-4E3B-405A-A759-3660C9CC60ECQ26741138-E554E91F-B278-43C5-84BF-F34CE9DC760BQ26775757-611B654C-0869-4B6E-A99F-356F4EA12BEDQ27004482-027CFAE1-DBE1-4B3F-A806-E758443E1676Q28481610-883D6556-C3D3-4828-9183-7803632796D2Q30498213-6861871A-2621-43EF-992F-0329845FE5B8Q35741836-AE22B8A5-D735-40BB-BC31-95183295EE93Q36928273-DD42F748-6366-4468-A6AE-4FFAE700D044Q37023145-AABF77CB-598F-4E33-8DA2-CDDEB167DD66Q37362655-87D1C040-35D3-469F-A25A-14B56A8FA620Q37409925-0E3D7768-AFE5-4769-AEF3-058818E4CFCEQ37724770-7D5DECB0-1F66-4EED-89AD-60B8D29B2B08Q37730293-94587EAE-A2D0-4BDC-9D48-82ED0CBA02D0Q37944716-83A1FC7B-AFFE-4454-9553-A2A1345AB3D6Q38724073-B78DF303-6167-4362-BC61-5B9B06FAF355Q38845761-8C87A843-8009-47B0-B5A9-EDDDC974EAFFQ43188224-BB2282C0-AB00-4334-A698-FC53A3B2C491Q45866393-2DFB51B6-10D6-4E11-A50A-35D48CF6B3D1
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Fluoroquinolones for treating tuberculosis
@ast
Fluoroquinolones for treating tuberculosis
@en
Fluoroquinolones for treating tuberculosis
@en-gb
Fluoroquinolones for treating tuberculosis
@nl
type
label
Fluoroquinolones for treating tuberculosis
@ast
Fluoroquinolones for treating tuberculosis
@en
Fluoroquinolones for treating tuberculosis
@en-gb
Fluoroquinolones for treating tuberculosis
@nl
prefLabel
Fluoroquinolones for treating tuberculosis
@ast
Fluoroquinolones for treating tuberculosis
@en
Fluoroquinolones for treating tuberculosis
@en-gb
Fluoroquinolones for treating tuberculosis
@nl
P2860
P3181
P1476
Fluoroquinolones for treating tuberculosis
@en
P2093
Lilia E Ziganshina
P2860
P304
P3181
P356
10.1002/14651858.CD004795.PUB3
P407
P577
2008-01-23T00:00:00Z